Contrave is a New Weight Loss Drug Promising to End Cravings
In a clinical study that has left researchers baffled, the new weight loss drug Contrave exceeded the U.S. Food and Drug Administration’s requirements to prove a weight loss drug’s efficacy. Contrave is actually a combination of two different drugs: bupropion and naltrexone, which are used to fight depression and smoking addiction respectively. This combination of pharmaceuticals is often prescribed in the treatment of alcohol and opiate addiction.
Its method for working its power impacts the brain’s craving and reward system. It is here that it unleashes its ability to block the craving drive that leads to overeating and binge-eating. 



